PATENT CLAIM ANALYSIS

Application Number: 15741981
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["424", "187100"]

Abstract:
Creation of HIV-1 vaccine immunogens based on glycopeptide scaffolds containing sequences from the V1/V2/V3 and C3 domains of HIV-1 gp120 that is able to bind multiple broadly neutralizing antibodies when expressed in mammalian cells that incorporate mannose-5 and mannose-9 glycans.

Claim (Index 10):
The method of  claim 9  wherein the primary immunization consists of monomeric gp120 or trimeric gp140 possessing the glycans required for the binding of broadly neutralizing antibodies from the PG9, PGT121, and PGT128 families, and the booster immunization consists of administration of V1/V2/V3/C3 scaffold antigens.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.10811
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15635064', '14427393', '15695753', '14363131', '14784501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7439316993585021
- 35 USC 102 Novelty (BERT): 0.618921021849621
- Combined Prediction Score: 0.731430631607614
- Mean Citation Score: 433.10390000000007
- Max Citation Score: 579.71185
- Similarity Product: 489.44700152978896

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test